Yonatan Lipsitz

Company: Lilium Therapeutics

Job title: CEO

Seminars:

Developing Delivery Technology to Precisely Target Lymphocyte Subsets 12:30 pm

Engineer delivery technology that can precisely target subsets of different lymphocytes, including specific autoreactive T-cells Emphasize how targeting autoreactive T-cells is important in tackling T-cell mediated autoimmune diseases such as Multiple Sclerosis and Type 1 Diabetes Outline how strong targeting is important to spare non-target T-cells, and thus enhance therapeutics safetyRead more

day: Day One AM